Cravatex Limited (BOM:509472)
India · Delayed Price · Currency is INR 367.00
+1.00 (0.27%)
At close: Feb 13, 2026
Cravatex Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,719 | 1,738 | 2,026 | 5,037 | 5,943 | 5,319 |
Other Revenue | 116.22 | 59.52 | 133.03 | 71.25 | 86.94 | 126.79 |
| 1,835 | 1,797 | 2,159 | 5,108 | 6,030 | 5,446 | |
Revenue Growth (YoY) | 6.90% | -16.77% | -57.73% | -15.30% | 10.74% | -37.29% |
Cost of Revenue | 965.8 | 1,061 | 1,395 | 3,638 | 4,142 | 3,656 |
Gross Profit | 869.25 | 735.75 | 764.24 | 1,469 | 1,888 | 1,790 |
Selling, General & Admin | 381.95 | 345.38 | 376.75 | 832.92 | 909.68 | 1,017 |
Other Operating Expenses | 422.95 | 346.83 | 330.81 | 863.29 | 919.74 | 759.98 |
Operating Expenses | 820.25 | 706.99 | 726.39 | 1,858 | 1,993 | 1,951 |
Operating Income | 48.99 | 28.76 | 37.85 | -388.29 | -104.8 | -161.41 |
Interest Expense | -3.55 | -4.05 | -3.96 | -133.6 | -134.78 | -143.21 |
Interest & Investment Income | 39.5 | 39.5 | 27.73 | 16.27 | 9.85 | 12.85 |
Currency Exchange Gain (Loss) | - | - | - | -4.32 | -2.63 | -0.28 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.08 | 0.08 |
EBT Excluding Unusual Items | 84.95 | 64.22 | 61.62 | -509.94 | -232.29 | -291.97 |
Gain (Loss) on Sale of Investments | 0.44 | 0.44 | 0.13 | 28.67 | 47.25 | 3.41 |
Gain (Loss) on Sale of Assets | - | - | 0.12 | 7.5 | -0.39 | -8.97 |
Asset Writedown | -0.93 | -0.93 | -0.25 | - | - | - |
Other Unusual Items | - | - | - | 1,057 | - | - |
Pretax Income | 84.45 | 63.72 | 61.6 | 583.33 | -185.44 | -297.53 |
Income Tax Expense | 18.05 | 15.44 | 13.33 | -5.99 | 13.44 | 8.58 |
Earnings From Continuing Operations | 66.4 | 48.28 | 48.28 | 589.33 | -198.88 | -306.11 |
Minority Interest in Earnings | - | - | - | - | 0.01 | 0.02 |
Net Income | 66.4 | 48.28 | 48.28 | 589.33 | -198.87 | -306.09 |
Net Income to Common | 66.4 | 48.28 | 48.28 | 589.33 | -198.87 | -306.09 |
Net Income Growth | 70.74% | 0.02% | -91.81% | - | - | - |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
EPS (Basic) | 25.69 | 18.68 | 18.68 | 228.05 | -76.96 | -118.45 |
EPS (Diluted) | 25.69 | 18.68 | 18.68 | 228.05 | -76.96 | -118.45 |
EPS Growth | 70.70% | 0.02% | -91.81% | - | - | - |
Free Cash Flow | - | 12.09 | 180.45 | 1,435 | -92.72 | -65.03 |
Free Cash Flow Per Share | - | 4.68 | 69.83 | 555.46 | -35.88 | -25.16 |
Dividend Per Share | - | 12.500 | 3.000 | 1.500 | 3.000 | 3.000 |
Dividend Growth | - | 316.67% | 100.00% | -50.00% | - | - |
Gross Margin | 47.37% | 40.94% | 35.39% | 28.77% | 31.31% | 32.87% |
Operating Margin | 2.67% | 1.60% | 1.75% | -7.60% | -1.74% | -2.96% |
Profit Margin | 3.62% | 2.69% | 2.24% | 11.54% | -3.30% | -5.62% |
Free Cash Flow Margin | - | 0.67% | 8.36% | 28.10% | -1.54% | -1.19% |
EBITDA | 57.81 | 37.26 | 45.91 | -313.17 | -26.16 | -78.73 |
EBITDA Margin | 3.15% | 2.07% | 2.13% | -6.13% | -0.43% | -1.45% |
D&A For EBITDA | 8.82 | 8.5 | 8.06 | 75.13 | 78.64 | 82.68 |
EBIT | 48.99 | 28.76 | 37.85 | -388.29 | -104.8 | -161.41 |
EBIT Margin | 2.67% | 1.60% | 1.75% | -7.60% | -1.74% | -2.96% |
Effective Tax Rate | 21.37% | 24.22% | 21.63% | - | - | - |
Revenue as Reported | 1,875 | 1,837 | 2,187 | 5,161 | 6,043 | 5,462 |
Advertising Expenses | - | 34.76 | 49.81 | 170.25 | 196.98 | 303.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.